← Back to Search

Chronic Care for Smoking Cessation

N/A

Waitlist Available

Led By Michael Fiore, MD, MPH, MBA

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Smoked cigarettes every day in the past 30 days (with or without other forms of tobacco or nicotine)

Be older than 18 years old

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upup to 18 months

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will compare a new healthcare approach, Comprehensive Chronic Care, with the Standard of Care, to see if it is more effective in helping smokers quit, reaches more people, and is more cost effective.

Eligible Conditions

Smoking Cessation

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You have smoked cigarettes every day in the last 30 days, with or without using other tobacco or nicotine products.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Participants with biochemically confirmed point-prevalence abstinence at 18 months

Secondary outcome measures

Cost Effectiveness measured by incremental cost-effectiveness ratio (ICER)

Group differences in Cessation Treatment

Number of Participants with 7-day point-prevalence abstinence at 12 months

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Comprehensive Chronic CareExperimental Treatment1 Intervention

ongoing proactive outreach designed to provide support and information about evidence-based smoking treatment, with access to individually validated treatments that are appropriate for patients who are: 1) unwilling quit but willing to reduce; 2) ready to quit; and 3) recovering from an unsuccessful quit attempt

Group II: Standard CareActive Control1 Intervention

involves one offer of cessation treatment (8 weeks of nicotine patch plus referral to the tobacco quit line), annually

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,140 Previous Clinical Trials

2,945,043 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,486 Previous Clinical Trials

41,264,937 Total Patients Enrolled

Michael Fiore, MD, MPH, MBAPrincipal InvestigatorUW Center of Tobacco Research and Intervention

1 Previous Clinical Trials

14,930 Total Patients Enrolled

Media Library

Comprehensive Chronic Care Clinical Trial Eligibility Overview. Trial Name: NCT05382221 — N/A

Smoking Cessation Research Study Groups: Standard Care, Comprehensive Chronic Care

Smoking Cessation Clinical Trial 2023: Comprehensive Chronic Care Highlights & Side Effects. Trial Name: NCT05382221 — N/A

Comprehensive Chronic Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05382221 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide an update on the enrollment status of this clinical trial?

"Clinicaltrials.gov indicates that this medical trial which was initially posted on August 8th, 2022 is now closed for recruitment. Nevertheless, there are still 144 other trials open to new participants at the current time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Breathe 2 Project 3: Comprehensive Chronic Care

2022. "Breathe 2 Project 3: Comprehensive Chronic Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05382221.